04
Nov

Regeneron is pouring more money than ever into its well-respected R&D operation, spending big on a cadre of late-stage candidates the Big Biotech believes can outshine its blockbuster eye treatment.

…read more

Source: Eyeing Eylea’s heirs, Regeneron spends more and more on R&D

    

0 No comments